Along with an increased PDGFRb expression as in CAFs, another study demonstrated that PSCs are preferentially trafficked to metastatic sites under the influence of PDA-EVs, via activation of the PDGFB pathway in distant cancer cells, hypothesizing that PDGFB could act as a chemokine to attract PSCs. This evidence concerns the gene PDGFB and Patent ductus arteriosus.